Image: 立法院 | Attribution | via Wikimedia Commons
Yang Ying, born in China, is a director of the pharmaceutical company Xiamen Amoytop Biotech. Her husband, Lan Chun, serves as the company's chairman. Yang Ying's career in the pharmaceutical industry has contributed to her estimated net worth of $1.3 billion. Her business acumen and leadership have been key factors in her financial success. This wealth stems from her self-made success in pharmaceuticals.
Yang Ying, currently 62 years old, is a director of Xiamen Amoytop Biotech, a Chinese pharmaceutical company founded in 1996. While information on her early life is limited, her career trajectory indicates a strong drive and focus on the healthcare industry.
Yang Ying's primary source of wealth comes from her involvement in Xiamen Amoytop Biotech. She, along with her husband, Lan Chun, who serves as chairman, have invested in and directed the company, which supplies recombinant protein drugs. Her dedication to the company has allowed her to accumulate wealth, placing her among China's wealthiest individuals.
The key to Yang Ying's success lies in her strategic involvement in the pharmaceutical sector. Amoytop's focus on recombinant protein drugs has positioned it within a growing healthcare market. Though specific details on strategies are limited, her position as a director implies significant decision-making roles within the company.
While not extensively documented, Yang Ying is associated with The Ying Family Charitable Foundation. The foundation supports various causes, including using the law to advance reproductive freedom, promoting research and education, and medical research. The foundation has assets of nearly $937,371.
Co-founded the pharmaceutical company which supplies recombinant protein drugs.
The Ying Family Charitable Foundation supports causes including reproductive freedom, research, education, and medical research.